EPCAM and neoplasm: Co-expression of membranous EpCAM and nuclear β-catenin in the tumor specimens in our study population was associated with an AFP level < 1200 ng/mL after SIOPEL neoadjuvant chemotherapy, indicating improved chemosensitivity.